DIALYSIS · CCN 452732

SHC South Laredo

LAREDO, TX 78040

DialysisProfitUS Renal Care, Inc.
$7.2M
TOTAL REVENUE
27.7%
OPERATING MARGIN
4 / 5
STAR RATING
15
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$7.2M
Total costs
$5.2M
Operating income (rev − costs)
$2.0M
Operating margin
27.7%
Total charges
$7.2M
Total treatments
18,801
Dialysis stations
25

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

15 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
97117—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.6497—
Fistula Rate
DFC_FISTULA_RATE
67.6125—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.2966—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
119.9126—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
1128—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
11125—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
22.5538—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
9.8117—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
26.686—
Standardized ED Visits Ratio
DFC_SEDR
1.0852—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
9.852—